In order to find antiosteoporotic agents from natural resources, 32 Indonesian medicinal plants were screened for their effects on osteoblast differentiation by using alkaline phosphatase (ALP) activity in MC3T3-E1 osteoblast cells as a marker. From the extract of Barleria lupulina, which showed the most potent activity, 13 iridoid glucosides, including three new ones [8-O-acetylipolamiidic acid (1), 8-O-acetyl-6-O-(p-methoxy-cis-cinnamoyl)shanzhiside (2), and 8-O-acetyl-6-O-(p-methoxy-trans-cinnamoyl)shanzhiside (3)] were identified. Among the 13 iridoid glucosides, ipolamiide (4) showed the most potent activity in a dose-dependent manner.
HolroydC, CooperC, DennisonE. (2008)Epidemiology of osteoporosis. Best Practice & Research. Clinical Endocrinology & Metabolism, 22, 671–685.
2.
WhyteMP, WenkertD, ClementsKL, McAlisterWH, MummS. (2003)Bisphosphonate-induced osteopetrosis.New England Journal of Medicine, 349, 457–463.
3.
GirotraM, RubinMR, BilezikianJP. (2006)The use of parathyroid hormone in the treatment of osteoporosis.Reviews in Endocrine & Metabolic Disorders, 7, 113–121.
4.
DawneyPA, SiegelM. (2006)Bone biology and the clinical implications for osteoporosis.Physical Therapy, 86, 77–91.
5.
LiJ-X, HareyamaT, TezukaY, ZhangY, MiyaharaT, KadotaS. (2005)Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity of osteoclast formation. Planta Medica, 71, 673–679.
6.
LiH, LiJ, PrasainJK, TezukaY, NambaT, MiyaharaT, TonamiS, SetoH, TadaT, KadotaS. (1998) Antiosteoporotic activity of the stems of Sambucus sieboldiana. Biological & Pharmaceutical Bulletin, 21, 594–598.
7.
LiH, MiyaharaT, TezukaY, NambaT, NemotoN, TonamiS, SetoH, TadaT, KadotaS. (1998)The effect of kampo formulae on bone resorption in vitro and in vivo. I. Active constituents of Tsu-kan-gan. Biological & Pharmaceutical Bulletin, 21, 1322–1326.
8.
ShiL, TezukaY, MiyaharaT, YinJ, NobukawaT, KadotaS. (2007)Inhibitory effect of constituents of Bu-Shen-Jian-Gu-Tang on osteoclast-like cell formation. Journal of Traditional Medicine, 24, 19–23.
9.
YinJ, TezukaY, KoudaK, TranQL, MiyaharaT, ChenY, KadotaS. (2004)In vivo antiosteoporotic activity of a fraction of Dioscorea spongiosa and its constituent, 22-O-methylprotodioscin. Planta Medica, 70, 220–226.
10.
ToriiY, HitomiK, YamagishiY.TsukagoshiN. (1996)Demonstration of alkaline phosphatase participation in the mineralization of osteoblasts by antisense RNA approach. Cell Biology International, 20, 459–464.
11.
PT Eisai Indonesia (1995) Medicinal Herb Index in Indonesia.PT Eisai Indonesia, Jakarta, pp. 247–248.
12.
ChopraRN, NayarSL, ChopraIC. (1968) Glossary of Indian Medicinal Plants (Suppl.). Academic Publishers, New Delhi, India, p. 20.
13.
SubaV, MurugesanT, KumaravelrajanR, MandalSC, SahaBP. (2005)Antiinflammatory, analgesic and antiperoxidative efficacy of Barleria lupulina Lindl. extract. Phytotherapy Research, 19, 695–699.
14.
SubaV, MurugesanT, RaoRB, GhoshL, PalM, MandalSC, SahaBP. (2004)Antidiabetic potential of Barleria lupulina extract in rats. Fitoterapia, 75, 1–4.
15.
SubaV, MurugesanT, RaoRB, PalM, MandalSC, SahaBP. (2002)Neuropharmacological profile of Barleria lupulina Lindl. extract in animal models. Journal of Ethnopharmacology, 81, 251–255.
16.
ChomnawangMT, SurassmoS, NukoolkarnVS, GritsanapanW. (2005)Antimicrobial effects of Thai medicinal plants against acne-inducing bacteria.Journal of Ethnopharmacology, 101, 330–333.
17.
SubaV, MurugesanT, PalM, MandalSC, SahaBP. (2004)Antiulcer activity of methanol fraction of Barleria lupulina Lindl. in animal models. Phytotherapy Research, 18, 925–929.
18.
YoosookC, PanpisutchaiY, ChaichanaS, SantisukT, ReutrakulV. (1999) Evaluation of anti-HSV-2 activities of Barleria lupulina and Clinacanthus nutans. Journal of Ethnopharmacology, 67, 179–187.
19.
ByrneLT, SasseJM, SkeltonBW, SuksamrarnA, WhiteAH. (1987)The minor iridoid glucosides of Barleria lupulina: isolation, crystal structure and plant growth-inhibiting properties of 6-O-acetylshanzhiside methyl ester. Australian Journal of Chemistry, 40, 785–794.
GüvenalpZ, ÖzbekH, ÜnsalarT, KazazC, DemirezerLÖ. (2006) Iridoid, flavonoid and phenylethanoid glycosides from Wiedemannia orientalis. Turkish Journal of Chemistry, 30, 391–400.
24.
TantisewieB, SticherO. (1975) Isolation of ipolamiide from Stachytarpheta indica. Phytochemistry, 14, 1462–1463.
25.
BiancoA, GuisoM, IavaroneC, Martini-BettoloR, TrogoloC. (1976)Iridoids. XXI. The stereochemistry of ipolamiide and the structure of its natural 8-O-acetyl derivative, ipolamiidoside. Gazzetta Chimica Italiana, 106, 947–953.
ErsözT, IvanchevaS, AkbayP, SticherO, ÇalisI. (2001) Iridoid and phenylethanoid glycosides from Phlomis tuberosaL. Zeitschrift für Naturforschung, 56C695–698.
30.
DamtoftS, JensenSR, NielsenBJ. (1982)Structural revision of barlerin and acetyl barlerin.Tetrahedron Letters, 23, 4155–4156.
31.
ChenJL, BlancP, StoddartCA, BoganM, RozhonEJ, ParkinsonN, YeZ, CooperR, BalickM, NanakornW, KernanMR. (1998)New iridoids from the medicinal plant Barleria prionitis with potent activity against respiratory syncytial virus. Journal of Natural Products, 61, 1295–1297.
32.
BenvenutiS, TaniniA, FredianiU, BianchiS, MasiL, CasanoR, BufalinoL, SerioM, BrandiML. (1991)Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line.Journal of Bone Mineral Research, 6, 987–996.
33.
KumegawaM, IkedaE, TanakaS, HanejiT, YoraT, SakagishiY, MinamiN, HiramatsuM. (1984)The effects of prostaglandin E2, parathyroid hormone, 1,25 dihydroxycholecalciferol, and cyclic nucleotide analogs on alkaline phosphatase activity in osteoblastic cells. Calcified Tissue International, 36, 72–76.
